“Tailored” antiplatelet bridging therapy with cangrelor: moving toward personalized medicine

References

• Brilakis ES, Banerjee S, Berger PB. Perioperative management of patients with coronary stents. J Am Coll Cardiol 2007;49(22):2145–2150. 10.1016/j.jacc.2007.02.046.
   PubMed Web of Science ®Google Scholar
• Capodanno D, Angiolillo DJ. Management of antiplatelet therapy in patients with coronary artery disease requiring cardiac and noncardiac surgery. Circulation 2013;128(25):2785–2798. 10.1161/CIRCULATIONAHA.113.003675.
   PubMed Web of Science ®Google Scholar
• Saia F, Belotti LMB, Guastaroba P, Berardini A, Rossini R, Musumeci G, Tarantini G, Campo G, Guiducci V, Tarantino F, et al. Risk of adverse cardiac and bleeding events following cardiac and noncardiac surgery in patients with coronary stent: how important is the interplay between stent type and time from stenting to surgery? Circ Cardiovasc Qual Outcomes 2016;9(1):39–47. 10.1161/CIRCOUTCOMES.115.002155.
   PubMed Web of Science ®Google Scholar
• Holcomb CN, Graham LA, Richman JS, Itani KMF, Maddox TM, Hawn MT. The incremental risk of coronary stents on postoperative adverse events. A matched cohort study. Ann Surg 2016;263(5):924–930. 10.1097/SLA.0000000000001246.
   PubMed Web of Science ®Google Scholar
• Rossini R, Tarantini G, Musumeci G, Masiero G, Barbato E, Calabrò P, Capodanno D, Leonardi S, Lettino M, Limbruno U, et al. A multidisciplinary approach on the perioperative antithrombotic management of patients with coronary stents undergoing surgery: surgery after stenting 2. JACC Cardiovasc Interv 2018;11(5):417–434. 10.1016/j.jcin.2017.10.051.
   PubMed Web of Science ®Google Scholar
• Kristensen SD, Knuuti J, Saraste A, Anker S, Bøtker HE, De Hert S, Ford I, Gonzalez-Juanatey JR, Gorenek B, Heyndrickx GR, et al. ESC/ESA guidelines on non-cardiac surgery: cardiovascular assessment and management: the joint task force on non-cardiac surgery: cardiovascular assessment and management of the European society of cardiology (ESC) and the European society of anaesthesiology (ESA). Eur Heart J 2014;35(35):2383–2431. 10.1093/eurheartj/ehu282.
   PubMed Web of Science ®Google Scholar
• KENGREAL (cangrelor) for injection. https://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/204958Orig1s000TOC.cfm
   Google Scholar
• Angiolillo DJ, Firstenberg MS, Price MJ, Tummala PE, Hutyra M, Welsby IJ, Voeltz MD, Chandna H, Ramaiah C, Brtko M, et al. Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial. JAMA - J Am Med Assoc 2012;307(3):265–274. 10.1001/jama.2011.2002.
   PubMed Web of Science ®Google Scholar
• Bowman S, Gass J, Weeks P. Antiplatelet therapy bridging with cangrelor in patients with coronary stents: a case series. Ann Pharmacother 2019;53(2):171–177. 10.1177/1060028018795840.
   PubMed Web of Science ®Google Scholar
• Kairouz V, Patel P, Franchi F, Deepa N, Suryadevara S, Soffer D, Pirris J, Zenni M, Bass T, Angiolillo D, et al. Cangrelor as an antiplatelet bridging strategy in patients with coronary artery disease undergoing cardiac and non-cardiac surgery. J Am Coll Cardiol 2018;71(11):A75. 10.1016/s0735-1097(18)30616-8.
   Web of Science ®Google Scholar
• Washam JB, Yerokun B, Patel CB, Welsby IJ, Milano CA, DeVore AD. Cangrelor use prior to left ventricular assist device surgery: a case series. J Thromb Thrombolysis 2018;46(2):131–133. 10.1007/s11239-018-1691-5.
   PubMed Web of Science ®Google Scholar
• Stern G, Rimsans J, Qamar A, Vaduganathan M, Bhatt DL. Contemporary parenteral antiplatelet bridging strategies: a single-centre real-world experience at a tertiary care centre. EuroIntervention 2018;14(3):e333–e335. 10.4244/EIJ-D-18-00036.
   PubMed Web of Science ®Google Scholar
• Galli M, Benenati S, Capodanno D, Franchi F, Rollini F, D’Amario D, Porto I, Angiolillo DJ. Guided versus standard antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis. Lancet 2021;397(10283):1470–1483. 10.1016/S0140-6736(21)00533-X.
   PubMed Web of Science ®Google Scholar
• Tantry US, Bonello L, Aradi D, Price MJ, Jeong YH, Angiolillo DJ, Stone GW, Curzen N, Geisler T, Ten Berg J, et al. Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding. J Am Coll Cardiol 2013;62(24):2261–2273. 10.1016/j.jacc.2013.07.101.
   PubMed Web of Science ®Google Scholar
• Aradi D, Kirtane A, Bonello L, Gurbel PA, Tantry US, Huber K, Freynhofer MK, Ten Berg J, Janssen P, Angiolillo DJ, et al. Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention. Eur Heart J 2015 July 14;36(27):1762–1771. 10.1093/eurheartj/ehv104.
   PubMed Web of Science ®Google Scholar
• Rossini R, Masiero G, Fruttero C, Passamonti E, Calvaruso E, Cecconi M, Carlucci C, Barzaghi N, Locatelli A, Mojoli M, et al. P2815Antiplatelet therapy with cangrelor in patients undergoing surgery after coronary stent implantation: a real-world bridging protocol experience. Eur Heart J 2019;40(Supplement_1): 10.1093/eurheartj/ehz748.1127
   Google Scholar
• Calnan MW, Crawford AN, Case A. Report of cangrelor bridge therapy for a diagnostic bronchoscopy with biopsy. J Pharm Pract 2020;33(2):231–235. 10.1177/0897190018795343.
   PubMed Web of Science ®Google Scholar
• Choxi R, Pillai A, Ahmed S, Jovin IS. Use of intravenous cangrelor as antiplatelet bridge therapy in a patient undergoing esophageal dilation procedure. Cardiovasc Revascularization Med 2020;21(11):94–95. 10.1016/j.carrev.2019.12.036.
   PubMed Web of Science ®Google Scholar
• Laehn SJ, Feih JT, Saltzberg MT, Garner Rinka JR. Pharmacodynamic-guided cangrelor bridge therapy for orthotopic heart transplant. J Cardiothorac Vasc Anesth 2019;33(4):1054–1058. 10.1053/j.jvca.2018.06.027.
   PubMed Web of Science ®Google Scholar
• Hu TY, Peeters SM, Nagasawa DT, Kamdar NV, Brook RP, Sun J, Park S, Moreland NC, Cruz D, Macyszyn L, et al. Cangrelor bridging within 6 months of a drug-eluting stent in a patient for emergency cervical spine surgery. A A Pract 2019;13(2):69–73. 10.1213/xaa.0000000000000994.
   PubMed Web of Science ®Google Scholar
• Godier A, Mesnil M, De Mesmay M, Dagois S, Thion LA, Dupont C, Mazighi M, Devys JM. Bridging antiplatelet therapy with cangrelor in patients with recent intracranial stenting undergoing invasive procedures: a prospective case series. Br J Anaesth 2019;123(1):e2–e5. 10.1016/j.bja.2019.03.019.
   PubMed Web of Science ®Google Scholar
• CAK N, Lao D, LAF L, Fb J, La H, Am S, RHM F, TF D, Lm B, FG L, et al. Platelet reactivity in patients with acute coronary syndromes awaiting surgical revascularization. J Am Coll Cardiol 2021;77(10):1277–1286. 10.1016/j.jacc.2021.01.015.
   PubMed Web of Science ®Google Scholar
• Stonko DP, Haut ER. Review of the french working group on perioperative hemostasis, French study group on thrombosis and hemostasis, and french society for anaesthesia and intensive care guidelines on management of antiplatelet therapy for nonelective invasive procedures or bleeding complications. JAMA Surg 2020 Sep 1;155(9):886–887. 10.1001/jamasurg.2020.2162. PMID: 32697287.
   PubMed Web of Science ®Google Scholar